Schroders Regulatory News (SDR)

Schroders plc

27 April 2023

Directorate Change

Schroders plc today announces that Iain Mackay will join the Board as an Independent Non-executive Director, effective 1 January 2024. He will also join the Audit and Risk Committee and the Nominations Committee.

Iain is currently Chief Financial Officer at GSK plc and was previously Chief Financial Officer of HSBC Holdings.

Elizabeth Corley, Chair of Schroders, said: "I am delighted that Iain has agreed to join the Board in January when he leaves GSK. In addition to his experience as Chief Financial Officer of FTSE 100 companies, Iain brings considerable knowledge of global organisations operating in many of the international markets in which we operate."

Biographical details of Iain are set out below. There are no further details required to be disclosed pursuant to Listing Rule 9.6.13 in connection with his appointment.

Biographical Details

Iain joined GSK and was appointed to the Board in January 2019, becoming Chief Financial Officer in April of that year. He is currently a member of the GSK leadership team and is responsible for Global Finance and several of GSK's key global functions including Investor Relations, Digital & Tech and Global Procurement. Iain will step down as CFO and Executive Director on 1 May 2023 and will leave GSK on 31 December 2023.

Prior to joining GSK, Iain was Group Finance Director at HSBC Holdings plc, a position he held for eight years. Iain has lived and worked in Asia, the US and Europe and before HSBC was at General Electric, Schlumberger Dowell and Price Waterhouse.

Iain holds an MA in Business Studies and Accounting and holds an Honorary Doctorate from Aberdeen University in Scotland. He is a member of the Institute of Chartered Accountants of Scotland. Iain serves as a Non-Executive Director, Chair of Audit & Risk Committee and Member of Remuneration Committee at National Grid plc. He is also a Member of the Court of the University of Aberdeen and Chair of its Remuneration Committee.

ENDS

For further information, please contact: